Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyperHAES after pediatric open-heart surgery
2007-000390-31Phase 4Active
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Jul 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Cardiovascular Malformation (CVM) comparing HyperHAES with Placebo isotonic saline (2 arms). Primary endpoint: Cardiac index. Started Jul 2009; status: active.
02
Drugs
HyperHAES
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2007-000390-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000390-31.